TenNor Therapeutics (Suzhou) Limited
Quick facts
Phase 3 pipeline
- Bismuth potassium citrate placebo capsules
This is a placebo formulation containing bismuth potassium citrate with no active therapeutic mechanism. - Clarithromycin placebo tablets
This is a placebo tablet with no active pharmacological mechanism. - Rifasutenizol capsules · Infectious Disease
Rifasutenizol is a rifamycin-class antibiotic that inhibits bacterial RNA polymerase to prevent transcription and translation in mycobacteria.
Phase 2 pipeline
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: